- Drug Pipelines
- August 2024
- 180 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Drug Pipelines
- July 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2024
- 145 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- July 2024
- 118 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- October 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- January 2025
- 250 Pages
Global
From €4771EUR$4,999USD£3,997GBP
- Report
- January 2025
- 250 Pages
Global
From €4771EUR$4,999USD£3,997GBP
- Report
- August 2024
- 240 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- May 2024
- 127 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- February 2025
- 217 Pages
Global
From €3865EUR$4,050USD£3,239GBP
- Report
- January 2025
- 295 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 62 Pages
Europe
From €2534EUR$2,655USD£2,123GBP
€2815EUR$2,950USD£2,359GBP
- Report
- May 2023
- 212 Pages
Global
From €1861EUR$1,950USD£1,559GBP
€3722EUR$3,900USD£3,119GBP
- Report
- December 2021
- 206 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more